세계의 췌장암 치료 시장 - 규모, 점유율, 동향 분석 : 유형별, 치료법별, 유통 채널별, 지역별, 부문 예측(2025-2030년)

Pancreatic Cancer Treatment Market Size, Share & Trends Analysis By Type, By Treatment, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

US $ 5,950 ￦ 8,609,000

Unprintable PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 불가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,950 ￦ 10,055,000

Printable PDF (5-User License)

PDF 보고서를 동일 기업의 5명까지 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,950 ￦ 12,949,000

Printable PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

췌장암 치료 시장의 성장과 동향 :

Grand View Research의 최신 보고서에 따르면 세계 췌장암 치료 시장 규모는 2030년까지 58억 4,000만 달러에 달할 것으로 예측됩니다.

이 시장은 2025년부터 2030년에 걸쳐 CAGR 12.30%를 나타낼 것으로 예측됩니다. 췌장암의 발병 피크는 65세부터 75세입니다. 따라서, 고령자 인구 증가도 예측 기간중의 성장을 가속할 것으로 예상됩니다.

2015년에 National Center for Biotechnology Information에 게재된 논문에 의하면, 췌장암은 가장 위험한 악성 종양의 하나이며, 미국에서는 암에 의한 사망 원인의 제4위입니다. 예측 기간 동안 시장 성장이 촉진되는 것으로 보입니다.

췌장암 치료 시장 보고서 하이라이트

• 본 조사에 따르면 췌장 외분비암은 췌장암 전체의 95% 이상을 차지하는 췌장암의 가장 일반적인 유형입니다.
• 치료 유형 중에서는 표적 치료가 가장 효과적인 치료 옵션이라고 생각되고 있어 건강한 세포를 손상시키지 않고 암세포의 증식과 확산을 저지하기 위해, 최대의 점유율을 차지하고 있습니다.
• 북미는 고도의 치료 옵션의 채용률이 높고, 헬스 케어 인프라가 고도로 발달하고 있기 때문에 2024년에 최대의 매출 점유율을 차지했습니다.
• 아시아태평양은 주로 정부 이니셔티브 증가, 췌장암 치료 옵션에 대한 의식 증가, 효과적인 치료를위한 고도로 정교한 의료 인프라의 가용성으로 예측 기간 동안 큰 성장을 표시될 것으로 예측됩니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 췌장암 치료 시장의 변수, 동향, 범위

• 상위 시장 전망
• 보조 시장 전망
• 시장 역학
  • 시장 성장 촉진요인 분석
  • 시장 성장 억제요인 분석
• 췌장암 치료 분석 도구
  • Porter's Five Forces 분석
  • PESTEL 분석

제4장 췌장암 치료 시장 : 유형별 추정·동향 분석

• 췌장암 치료 시장 : 유형 부문 대시보드
• 췌장암 치료 시장 : 유형별 변동 분석, 백만 달러, 2024년·2030년
• 외분비
• 내분비

제5장 췌장암 치료 시장 : 치료의 추정·동향 분석

• 췌장암 치료 시장 : 치료 부문 대시보드
• 췌장암 치료 시장 : 치료 변동 분석, 백만 달러, 2024· 2030
• 화학요법
• 방사선치료
• 기타

제6장 췌장암 치료 시장 : 유통 채널의 추정·동향 분석

• 췌장암 치료 시장 : 유통 채널 부문 대시보드
• 췌장암 치료 시장 : 유통 채널 변동 분석, 백만 달러, 2024년· 2030년
• 병원 약국
• 소매 약국
• 기타

제7장 췌장암 치료 시장 :지역 추정·동향 분석

• 췌장암 치료 시장 점유율, 지역별, 2024년·2030년, 백만 달러
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 영국
  • 독일
  • 프랑스
  • 이탈리아
  • 스페인
  • 덴마크
  • 노르웨이
  • 스웨덴
• 아시아태평양
  • 중국
  • 일본
  • 인도
  • 한국
  • 호주
  • 태국
• 라틴아메리카
  • 브라질
  • 아르헨티나
• 중동 및 아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 쿠웨이트
  • 남아프리카

제8장 경쟁 구도

• 최근의 동향과 영향 분석, 주요 시장 진출기업별
• 기업 분류
• 기업 히트맵 분석
• 기업 프로파일
  • Accuray Incorporated
  • AstraZeneca
  • Novartis AG
  • Pfizer Inc.
  • Genentech, Inc.(F. Hoffmann-La Roche Ltd)
  • Bristol-Myers Squibb Company
  • Ipsen Pharma
  • Eli Lilly and Company
  • Siemens Healthineers AG(Varian Medical Systems, Inc., part of the company)
  • Elekta AB

JHS

영문 목차

영문목차

Pancreatic Cancer Treatment Market Growth & Trends:

The global pancreatic cancer treatment market size is anticipated to reach USD 5.84 billion by 2030, according to a new report by Grand View Research, Inc. The market is projected to grow at a CAGR of 12.30% from 2025 to 2030. Increasing tobacco consumption, smoking, obesity, and growing awareness pertaining to various treatment options available are propelling the market growth at a global level. The peak incidence of pancreatic cancer is seen in the age group of 65 to 75 years. Thus, growing geriatric population is also expected to drive the growth during the forecast period.

According to an article published in the National Center for Biotechnology Information in 2015, pancreatic cancer is one of the most dangerous malignancies and is the fourth most common cause of cancer deaths in the U.S. Furthermore, pancreatic cancer is expected to be the second common cause of death in the U.S., by 2030. These factors together would propel the market growth in the forecast period.

Pancreatic Cancer Treatment Market Report Highlights:

• The study suggests that exocrine cancer is by far the most common type of pancreatic cancer accounting for more than 95% of the overall pancreatic cancer types.
• Among the treatment types, targeted therapy occupied the largest share since it is considered as the most effective treatment option, which blocks the growth and spread of cancer cells without damaging healthy cells.
• North America dominated the segment with the largest revenue share in 2024 due to high adoption rate of advanced treatment options and highly developed healthcare infrastructure.
• Asia Pacific is anticipated to show a significant growth during the forecast period, mainly due to increasing government initiatives, growing awareness regarding the treatment options for pancreatic cancer, and the availability of highly sophisticated medical infrastructure for effective treatment.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Pancreatic Cancer Treatment Market Variables, Trends, & Scope

• 3.1. Parent Market Outlook
• 3.2. Ancillary Market Outlook
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
    • 3.3.1.1. Rising Prevalence of Pancreatic Cancer Globally
    • 3.3.1.2. Advancements in Modern Therapeutics
    • 3.3.1.3. Growing Investments in Pancreatic Cancer R&D
  • 3.3.2. Market Restraints Analysis
    • 3.3.2.1. High Cost of Advanced Therapies
    • 3.3.2.2. Stringent Regulatory and Reimbursement Challenges
• 3.4. Pancreatic Cancer Treatment Analysis Tools
  • 3.4.1. Porter's Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. Pancreatic Cancer Treatment Market: By Type Estimates & Trend Analysis

• 4.1. Pancreatic Cancer Treatment Market: Type Segment Dashboard
• 4.2. Pancreatic Cancer Treatment Market: By Type Movement Analysis, USD Million, 2024 & 2030
• 4.3. Exocrine
  • 4.3.1. Exocrine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.4. Endocrine
  • 4.4.1. Endocrine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Pancreatic Cancer Treatment Market: Treatment Estimates & Trend Analysis

• 5.1. Pancreatic Cancer Treatment Market: Treatment Segment Dashboard
• 5.2. Pancreatic Cancer Treatment Market: By Treatment Movement Analysis, USD Million, 2024 & 2030
• 5.3. Chemotherapy
  • 5.3.1. Chemotherapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.4. Radiation Therapy
  • 5.4.1. Radiation Therapy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.5. Others
  • 5.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Pancreatic Cancer Treatment Market: Distribution Channel Estimates & Trend Analysis

• 6.1. Pancreatic Cancer Treatment Market: Distribution Channel Segment Dashboard
• 6.2. Pancreatic Cancer Treatment Market: Distribution Channel Movement Analysis, USD Million, 2024 & 2030
• 6.3. Hospital Pharmacies
  • 6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.4. Retail Pharmacies
  • 6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.5. Others
  • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Pancreatic Cancer Treatment Market: Regional Estimates & Trend Analysis

• 7.1. Pancreatic Cancer Treatment Market Share, By Region, 2024 & 2030, USD Million
• 7.2. North America
  • 7.2.1. North America Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2.2. U.S.
    • 7.2.2.1. U.S. Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2.3. Canada
    • 7.2.3.1. Canada Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.2.4. Mexico
    • 7.2.4.1. Mexico Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.3. Europe
  • 7.3.1. Europe Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.2. UK
    • 7.3.2.1. UK Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.3. Germany
    • 7.3.3.1. Germany Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.4. France
    • 7.3.4.1. France Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.5. Italy
    • 7.3.5.1. Italy Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.6. Spain
    • 7.3.6.1. Spain Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018- 2030 (USD Million)
  • 7.3.7. Denmark
    • 7.3.7.1. Denmark Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.8. Norway
    • 7.3.8.1. Norway Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3.9. Sweden
    • 7.3.9.1. Sweden Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.4. Asia Pacific
  • 7.4.1. Asia Pacific Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.2. China
    • 7.4.2.1. China Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.3. Japan
    • 7.4.3.1. Japan Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.4. India
    • 7.4.4.1. India Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.5. South Korea
    • 7.4.5.1. South Korea Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.6. Australia
    • 7.4.6.1. Australia Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4.7. Thailand
    • 7.4.7.1. Thailand Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.5. Latin America
  • 7.5.1. Latin America Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. Brazil
    • 7.5.2.1. Brazil Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Argentina
    • 7.5.3.1. Argentina Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Middle East and Africa
  • 7.6.1. Middle East and Africa Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. Saudi Arabia
    • 7.6.2.1. Saudi Arabia Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. UAE
    • 7.6.3.1. UAE Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. Kuwait
    • 7.6.4.1. Kuwait Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. South Africa
    • 7.6.5.1. South Africa Pancreatic Cancer Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis by Key Market Participants
• 8.2. Company Categorization
• 8.3. Company Heat Map Analysis
• 8.4. Company Profiles
  • 8.4.1. Accuray Incorporated
    • 8.4.1.1. Participant's Overview
    • 8.4.1.2. Financial Performance
    • 8.4.1.3. Product Benchmarking
    • 8.4.1.4. Recent Developments/ Strategic Initiatives
  • 8.4.2. AstraZeneca
    • 8.4.2.1. Participant's Overview
    • 8.4.2.2. Financial Performance
    • 8.4.2.3. Product Benchmarking
    • 8.4.2.4. Recent Developments/ Strategic Initiatives
  • 8.4.3. Novartis AG
    • 8.4.3.1. Participant's Overview
    • 8.4.3.2. Financial Performance
    • 8.4.3.3. Product Benchmarking
    • 8.4.3.4. Recent Developments/ Strategic Initiatives
  • 8.4.4. Pfizer Inc.
    • 8.4.4.1. Participant's Overview
    • 8.4.4.2. Financial Performance
    • 8.4.4.3. Product Benchmarking
    • 8.4.4.4. Recent Developments/ Strategic Initiatives
  • 8.4.5. Genentech, Inc. (F. Hoffmann-La Roche Ltd)
    • 8.4.5.1. Participant's Overview
    • 8.4.5.2. Financial Performance
    • 8.4.5.3. Product Benchmarking
    • 8.4.5.4. Recent Developments/ Strategic Initiatives
  • 8.4.6. Bristol-Myers Squibb Company
    • 8.4.6.1. Participant's Overview
    • 8.4.6.2. Financial Performance
    • 8.4.6.3. Product Benchmarking
    • 8.4.6.4. Recent Developments/ Strategic Initiatives
  • 8.4.7. Ipsen Pharma
    • 8.4.7.1. Participant's Overview
    • 8.4.7.2. Financial Performance
    • 8.4.7.3. Product Benchmarking
    • 8.4.7.4. Recent Developments/ Strategic Initiatives
  • 8.4.8. Eli Lilly and Company
    • 8.4.8.1. Participant's Overview
    • 8.4.8.2. Financial Performance
    • 8.4.8.3. Product Benchmarking
    • 8.4.8.4. Recent Developments/ Strategic Initiatives
  • 8.4.9. Siemens Healthineers AG (Varian Medical Systems, Inc., part of the company)
    • 8.4.9.1. Participant's Overview
    • 8.4.9.2. Financial Performance
    • 8.4.9.3. Product Benchmarking
    • 8.4.9.4. Recent Developments/ Strategic Initiatives
  • 8.4.10. Elekta AB
    • 8.4.10.1. Participant's Overview
    • 8.4.10.2. Financial Performance
    • 8.4.10.3. Product Benchmarking
    • 8.4.10.4. Recent Developments/ Strategic Initiatives

관련자료